Author

Y. Shiraishi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Persistence of guideline-directed medical therapy after heart failure hospitalisation in older adults with cancer

Heart failure (HF) and cancer frequently coexist in older adults. Although guideline-directed medical therapy (GDMT) is the foundation of contemporary HF management, its real-world implementation and persistence in patients with cancer remain poorly characterized. This gap is clinically relevant because interrupt...

K. Daigo, S. Nishimura, H. Kumamaru et al. · European Heart Journal · 0 citations

Open access Oct 2026

Age-related differences in adverse events among vericiguat-treated patients with heart failure: insights from the VERIFY-HF registry

Vericiguat improves outcomes in patients with worsening heart failure with reduced ejection fraction (HFrEF). However, its safety profile in very elderly patients remains poorly characterized in routine clinical practice, where multimorbidity and renal dysfunction are prevalent. We aimed to evaluate age-related d...

R. Matsukawa, Y. Mukai, W. Fujimoto et al. · European Heart Journal · 0 citations

Case report Open access Jun 2026

Progression of chronic thromboembolic pulmonary disease without pulmonary hypertension in a case with JAK2 V617F mutation

Chronic thromboembolic pulmonary disease (CTEPD) is characterized by persistent obstruction of pulmonary arteries with organized thrombotic materials. Patients with CTEPD without pulmonary hypertension (PH) are generally considered unlikely to progress to chronic thromboembolic pulmonary hypertension (CTEPH). Here, we...

M. Momoi, Atsushi Anzai, Takashi Maeda et al. · Journal of Cardiology Cases · 0 citations